High Granular Tick Data API: US Stocks Learn more

Fulcrum Therapeutics Inc icon

Fulcrum Therapeutics Inc (FULC NASDAQ) stock market data APIs

$6.9171 0.13(1.9%)
as of May 7, 2026
Try our APIs with free plan!

Fulcrum Therapeutics Inc Financial Data Overview

Price chart is built with Anychart

Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops small molecules to improve the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its clinical-stage product candidate is pociredir, a fetal hemoglobin inducer, which is in phase 1b clinical trial for the treatment of sickle cell disease and beta-thalassemia. The company also discovers programs for the treatment of diamond-blackfan anemia, Bone Marrow Failure Syndromes, novel fetal hemoglobin inducers, fibrotic disorders. It has licensce agreement with CAMP4 which includes certain small molecule compounds, composition of matter and method of use patent rights, and know-how to research, develop, manufacture, use, and commercialize. Fulcrum Therapeutics, Inc. was Incorporated in 2015 and is headquartered in Cambridge, Massachusetts.

Prev. Close 6.9171
Open 7.0437
High 7.1353
Low 6.8818
52 wk Range 5.37-15.7399
Market Cap 458 M
Shares Outstanding 66 633 K
EPS -0.31
Beta 3.008

* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.


ETFs with Fulcrum Therapeutics Inc (top by weight)

Ticker
100-day Price Change
Weight
PINK.US Simplify Exchange Traded Funds - Simplify Health Care ETF
-1.06 (-2.9%)
0.34
VFMO.US Vanguard U.S. Momentum Factor
18.9 (9.12%)
0.08
IWC.US iShares Micro-Cap ETF
13.14 (7.7%)
0.08
BTEC.SW iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) USD
-0.07 (-0.82%)
0.04
2B70.F iShares NASDAQ US Biotechnology UCITS ETF
0.06 (0.79%)
0.04
IBB.US iShares Biotechnology ETF
-3.8 (-2.19%)
0.04

* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.


Why to choose EODHD?

Prices start at $19.99

24/7 Live support

Robust, powerful and reliable data

API Simplicity of a few lines of code


Try our APIs
with free plan!

Or get access to advanced financial data starting only $19.99

TRY NOW

Get Fulcrum Therapeutics Inc data using free add-ons & libraries


Get Fulcrum Therapeutics Inc Fundamental Data

Fulcrum Therapeutics Inc logo

Fulcrum Therapeutics Inc Fundamental data includes:

  • Net Revenue:
  • EBITDA: -85 177 000
  • Earnings Per Share:
  • Income Statements
  • Balance Sheets
  • Cash flows

Plans with Fundamental data

Starting from

$ 59.99 /mo.
COMPARE PLANS

End-of-day & Earnings data

Get Fulcrum Therapeutics Inc Earnings data

Corporate Events Calendar & News package for

$ 19.99 /mo.

What’s included:

  • Latest Release: 2026-02-26
  • EPS/Forecast: -0.3055
GET THE PACKAGE

Get Fulcrum Therapeutics Inc End-of-day data

EOD Historical Data package for

$ 19.99 /mo.

What’s included:

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
GET THE PACKAGE

Fulcrum Therapeutics Inc News

Get Fulcrum Therapeutics Inc fresh news feed via Financial News API

Corporate Events Calendar & News package for

$19.99/mo.

Try our APIs
with free plan!

Or get access to advanced financial data starting only $19.99

TRY NOW
  • Flexibility: No long-term commitments, just a minimum of one month
  • Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.

What’s included:

  • API Calls per Day: 100 000/day
  • API Requests per Min.: 1000/minute
  • Type of Usage: Personal use

Data access:

Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.

GET THE PACKAGE
Live chat support

Send the request

Leave your email and our team will contact you ASAP.